The presence of intraductal carcinoma of the prostate is closely associated with poor prognosis: a systematic review and meta-analysis.

Author: Yu-Cong ZHANG ¹ ; Guo-Liang SUN ¹ ; De-Lin MA ² ; Chao WEI ¹ ; Hao-Jie SHANG ¹ ; Zhuo LIU ¹ ; Rui LI ¹ ; Tao WANG ¹ ; Shao-Gang WANG ¹ ; Ji-Hong LIU ¹ ; Xia-Ming LIU ¹
Author Information

1. Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
2. Department of Endocrine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Publication Type:Research Support, Non-U.S. Gov't
Keywords: clinicopathological; intraductal carcinoma of the prostate; meta-analysis; prognostic; prostate cancer
From: Asian Journal of Andrology 2021;23(1):103-108
CountryChina
Language:English
Abstract: We aimed to confirm the predictive ability of the presence of intraductal carcinoma of the prostate (IDC-P) for prognosis and the associations between IDC-P and clinicopathological parameters. Studies were identified in PubMed, Cochrane Library, EMBASE, Web of Science, and SCOPUS up to December 1, 2019. Hazard ratios (HRs) for survival data and odds ratios for clinicopathological data with 95% confidence intervals (CIs) were extracted. Heterogeneity was evaluated by the I